Summary
Updated Aug 31, 2026
Richard Jacinto II is 10% Owner of DiaMedica Therapeutics Inc. (DMAC). 1 SEC Form 4 filing on record, dated 25 July 2025. Most recent open-market trade: bought $1.40M of DMAC on 25 July 2025. Lifetime open-market purchases: $1.40M.
Recent Transactions
1Every recent SEC Form 4 transaction Richard Jacinto II has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard Jacinto II files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jan Stahlberg - $5.96M of DMAC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Richard Jacinto II?
Richard Jacinto II is a corporate insider, tracked as 10% Owner of DiaMedica Therapeutics Inc. (DMAC). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Richard Jacinto II last file a Form 4?
The only primary Form 4 on record is dated 25 July 2025.
Has Richard Jacinto II been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1.40M) and 0 open-market sales across all tracked filings.
Where can I see all of Richard Jacinto II's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Richard Jacinto II and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
